Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.

NCT03722680 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

80

Enrollment

OTHER

Sponsor class

Stopped Lack of treatment, sponsor decision.

Conditions

Oxaliplatin-induced Peripheral Neuropathy

Interventions

DRUG: Riluzole
DRUG: Placebo Oral Tablet

Sponsor

UNICANCER